Can I Take 5-HTP with Tretinoin?

Print or save as PDF

What tretinoin does

Topical tretinoin is a prescription retinoid. Renova (tretinoin cream 0.02%) is approved only as an adjunct to a comprehensive skin care and sun avoidance program for mitigation of fine facial wrinkles, and its label states plainly that it does not eliminate wrinkles, repair sun-damaged skin or reverse photoaging [1].

The Renova label's clinical pharmacology section says tretinoin activates three retinoic acid receptors (RAR alpha, RAR beta and RAR gamma), which may modify gene expression, protein synthesis and epithelial cell growth. It adds that it has not been established whether the clinical effects come from receptor activation, from irritation, or from both [1].

How much reaches the bloodstream

The same label reports that transdermal absorption of tretinoin from various topical formulations ranged from 1% to 31% of the applied dose, depending on whether it went on healthy or dermatitic skin. In a study of a 0.05% cream in healthy men, absorption was less than 2% after a single application (n=7) and after 28 days of daily use (n=7), and the extent of bioavailability was lower after repeated application. No percutaneous absorption study was run with the 0.02% Renova cream itself [1].

What 5-HTP does

5-HTP is the immediate precursor of serotonin. The body converts tryptophan to 5-HTP using tryptophan hydroxylase, the rate-limiting step in serotonin production, then converts 5-HTP to serotonin with aromatic amino acid decarboxylase; serotonin is further converted to melatonin. Because 5-HTP sits after the rate-limiting step, it raises serotonin more directly than tryptophan does [3].

Some of that conversion happens outside the brain. Peripheral decarboxylase inhibitors such as carbidopa block it and increase the amount of 5-HTP reaching the central nervous system [6].

5-HTP is sold in the US as a dietary supplement. A Drugs@FDA search returned no approved drug application with 5-hydroxytryptophan as the active ingredient [2].

Doses used in human studies include 50 mg daily for 4 weeks in a crossover trial in Parkinson's disease with depression, 100 mg daily for 12 weeks in a single-blinded trial of 30 adults with a mean age of 66 in Singapore, and 300 mg daily for 28 days alongside clomipramine 50 mg in a double-blind trial of 26 hospitalized depressed patients published in 1983. These are study doses, not recommended doses. A review reports nausea and vomiting at doses above 100 mg [3][7][8].

Does 5-HTP interact with tretinoin?

We found no study that tested the pair. The Renova 0.02% cream label's drug interactions section lists topical products that irritate the skin (medicated or abrasive soaps, shampoos, cleansers, astringents, high-alcohol products, waxes) and drugs known to be photosensitizers, naming thiazides, tetracyclines, fluoroquinolones, phenothiazines and sulfonamides. 5-HTP does not appear on that list [1]. That is one tretinoin product's label; other tretinoin creams and gels carry their own labeling.

Their described actions differ: topical tretinoin activates retinoic acid receptors [1], while 5-HTP is converted to serotonin [3]. We found no study of whether those differences matter when the two are used together. Not being listed on a label is not the same as having been studied, so the combination is untested rather than proven compatible.

Where the 5-HTP risk actually comes from

The concern that follows 5-HTP is serotonin syndrome, mainly when it is combined with serotonergic drugs. A 1991 review of 12 reports covering 38 cases found the syndrome most commonly resulted from an interaction between serotonergic agents and monoamine oxidase inhibitors. The most frequent features were changes in mental status, restlessness, myoclonus, hyperreflexia, diaphoresis, shivering and tremor. Once treatment was instituted, the syndrome typically resolved within 24 hours, although confusion could last for days, and death has been reported [4].

A 2026 systematic review of 764 published adult cases found that of 645 cases from regular prescriptions, 92.9% involved two or more agents. Monotherapy cases were milder. Trazodone was the most connected antidepressant and fentanyl and tramadol the most connected non-antidepressants. Mortality was 18.0% in cases following suicide attempts and 5.1% in regular-prescription cases [9]. That review does not single out 5-HTP; it shows that most regular-prescription cases involved combinations.

The human 5-HTP data are thin and mostly case-level. One case report describes mania in a patient taking an MAOI who added a hydroxytryptophan supplement, with no personal or family history of bipolar disorder [10]. The strongest precedent for the precursor class comes from L-tryptophan: five cases of toxic reaction after fluoxetine plus L-tryptophan, reported in 1986 [5]. On the other side, a 1983 double-blind trial added 5-HTP 300 mg/day to clomipramine 50 mg/day for 28 days in 26 depressed inpatients and reported better depression scores than clomipramine plus placebo. The abstract does not report serotonin syndrome, but it is a small, old, supervised study that does not establish safety for unsupervised use [8].

None of these reports involve tretinoin, and the Renova label's pharmacology section does not describe serotonin activity [1].

Supplement quality and the EMS question

The 1989 eosinophilia-myalgia syndrome (EMS) outbreak that removed L-tryptophan from the market was traced to contaminated synthetic L-tryptophan from a single manufacturer, a contaminant in the tryptophan rather than tryptophan itself. CDC surveillance counted 1,345 people who met the EMS case definition, and 26 of them (2%) reported never using L-tryptophan [12][13].

For 5-HTP, chemical analyses have found related contaminants. All eight commercial 5-HTP samples tested in 1999 contained three or more members of the peak X family [14], and in 2003 the main one, X1, was identified as 4,5-tryptophan-dione, a putative neurotoxin, present in six over-the-counter samples at 0.5% to 10.3% of the amount found in case-implicated 5-HTP [15]. A 2004 safety review takes the opposite view: no definitive cases of 5-HTP toxicity had emerged in about 20 years of worldwide use apart from one unresolved Canadian case, and it says peak X lacks credibility because of chromatographic artifacts and tiny concentrations [12]. The question is unresolved, and no confirmed modern EMS epidemic from 5-HTP has been documented.

Practical points

• Tretinoin goes on the skin; the Renova label reports that almost all patients in its studies had local reactions such as peeling, dry skin, burning, stinging, erythema and itching. The label also warns of heightened sunburn susceptibility and advises minimizing sun exposure and using sunscreen (minimum SPF 15) and protective clothing [1].
• The main documented concern with 5-HTP is combining it, or related serotonin precursors, with serotonergic drugs, especially MAOIs. Human evidence is mostly case reports and L-tryptophan precedents [5][4][10].
• 5-HTP is not FDA-approved [2], and we found no trial that tested it alongside topical tretinoin.

For more information about topical tretinoin, see tretinoin.